Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nad & Tad Urge Men to Get in Touch With Their Testes
  • USA - English

Testicular Cancer Awareness Campaign Aims to Start a Conversation About Self-Exams Using Humor


News provided by

Testicular Cancer Foundation

Apr 02, 2019, 06:00 ET

Share this article

Share toX

Share this article

Share toX

AUSTIN, Texas, April 2, 2019 /PRNewswire-PRWeb/ -- The Testicular Cancer Foundation (TCF) is announcing a new campaign featuring two animated testes, Nad & Tad, to jumpstart a conversation about the importance of self-exams and checking for testicular cancer. Launching during Testicular Cancer Awareness Month, the humorous campaign targets men ages 15 to 34, those most commonly affected by the disease. With incidence rates on the rise, testicular cancer often goes undetected due to a lack of education on why and how to proactively screen for symptoms.

Nad & Tad touchpoints during Testicular Cancer Awareness Month:

  • Online Web Series at NadandTad.com: Nad & Tad teach men how to identify the signs of testicular cancer and perform a self-exam through a series of short, funny videos created by award-winning animators Aardman Nathan Love (of Wallace and Gromit fame) and healthcare advertising agency Patients & Purpose.
  • "Nad & Tad-ify" Yourself on Snapchat: During the month of April, Snapchat users can create a personalized Nad & Tad video. Life as a testicle never looked so good. Unlock the lens here.
  • Limited Edition Custom Brew in New York City: Cheers! Gun Hill Brewing Company in NYC is releasing a limited edition Nad & Tad Odd Ball Ale that will be available in bars around the city. In addition, the testicular duo can be found on coasters and posters to further engage men in places where conversations around cancer are seldom heard. For a list of breweries and bars serving Odd Ball Ale, visit NadandTad.com.
  • Shareable Content on Instagram, Facebook, Snapchat, and Twitter: Follow the infamous pair on social media and join the conversation #NadandTad.

"Fighting a disease that affects a demographic that is young and feels invincible is an uphill battle, but we are taking it head on," says Matt Ferstler, TCF founder. "Being the only full-time staffed testicular cancer group and leading provider of education materials in the country, it is our mission and obligation to ensure every male knows the warning signs of the disease and how to perform a testicular self-exam."

TCF was founded by Ferstler, who was diagnosed with testicular cancer at the age of 22. Frustrated that he didn't know the warning signs, the importance of a self-exam, or that he was susceptible to this disease, Ferstler turned his frustration into action. In 2009, the Testicular Cancer Foundation was born and has since been a driving force in the men's health and testicular cancer arena.

"We are beyond excited about our partnership with Patients & Purpose and the 'Get in Touch With Your Testes' campaign. With Nad & Tad's help, we have the potential to reach a huge audience and educate them on the importance of self-exams. It also doesn't hurt that these dudes, if I can call them that, are hilarious!" said Kenny Kane, TCF CEO.

"By bringing awareness to testicular cancer, we can help close the education gap and motivate men to get in touch with their testes. And what better way to do that than with two hilarious testicles who are on the ball about testicular cancer?" said Dina Peck, Managing Partner, Executive Creative Director at Patients & Purpose. "We are thrilled about our partnership with TCF."

About the Testicular Cancer Foundation
The Testicular Cancer Foundation provides education and support to young men to raise awareness about testicular cancer. TCF also supports families of testicular cancer patients and shares its resources with the medical and healthcare communities, schools, and various young men's groups.

About Patients & Purpose
Patients & Purpose is a full-service, award-winning agency dedicated to patients and marketing health brands. They are multichannel experts, with deep emerging technology expertise, and develop novel approaches to patient and consumer engagement. Patients & Purpose is the go-to patient agency for Omnicom Health Group. For more information, please visit http://www.patientsandpurpose.com.

About Aardman Nathan Love
Aardman Nathan Love is an innovative animation, design, and development studio located in NYC. Driven by a passion to tell great stories and connect with audiences around the globe, Aardman Nathan Love develops memorable characters, imaginative worlds, and engaging narratives for television, film, interactive, and more.

About Gun Hill Brewing Company
Founded in 2014 and located in the Bronx, Gun Hill Brewing Company is dedicated to bringing high-quality, hand-crafted beer to the people of NY.

SOURCE Testicular Cancer Foundation

Related Links

http://testicularcancer.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.